UNLABELLED: Hepatitis B virus (HBV) can be classified into at least eight genotypes, A-H. We evaluated the distribution HBV genotypes among patients with chronic infection. METHODS: We consecutively evaluated adult patients with chronic HBV infection from Salvador, Brazil. Patients were classified according to HBV infection chronic phases based on HBV-DNA levels and presence of serum HBV markers. HBV-DNA was qualitatively and quantitatively detected in serum by polymerised chain reaction (PCR). Isolates were genotyped by comparison of amino acid mutations and phylogenetic analysis. RESULTS: One-hundred and fourteen patients were evaluated. HBV-DNA was positive in 96 samples. HBV genotype was done in 76. Mean age was 36 +/- 11.3. In 61 of 76 cases subjects were classified as inactive HBsAg carriers. Their mean HBV serum level was 1760 copies/ml and 53 of 61 were infected with HBV genotype A, seven with HBV genotype F and one with genotype B. Twelve of the 76 patients had detectable hepatitis B e-antigen (HBeAg) in serum. Ten were infected with HBV genotype A and two with genotype F; most had increased alanine aminotransferase and high HBV-DNA levels. Three patients were in the immunotolerant phase, two were infected with HBV genotype A and one with genotype F. HBV subtyping showed subtypes adw2 and adw4. CONCLUSIONS: HBV genotype A adw2 and genotype F adw4 were the most prevalent isolates found. We could not find differences in genotype distribution according to HBV clinical phases and DNA levels. We did not detect HBV genotype D in contrast to a previous study in our center with acute hepatitis B. All inactive HBsAg carriers had low HBV-DNA levels.
UNLABELLED: Hepatitis B virus (HBV) can be classified into at least eight genotypes, A-H. We evaluated the distribution HBV genotypes among patients with chronic infection. METHODS: We consecutively evaluated adult patients with chronic HBV infection from Salvador, Brazil. Patients were classified according to HBV infection chronic phases based on HBV-DNA levels and presence of serum HBV markers. HBV-DNA was qualitatively and quantitatively detected in serum by polymerised chain reaction (PCR). Isolates were genotyped by comparison of amino acid mutations and phylogenetic analysis. RESULTS: One-hundred and fourteen patients were evaluated. HBV-DNA was positive in 96 samples. HBV genotype was done in 76. Mean age was 36 +/- 11.3. In 61 of 76 cases subjects were classified as inactive HBsAg carriers. Their mean HBV serum level was 1760 copies/ml and 53 of 61 were infected with HBV genotype A, seven with HBV genotype F and one with genotype B. Twelve of the 76 patients had detectable hepatitis B e-antigen (HBeAg) in serum. Ten were infected with HBV genotype A and two with genotype F; most had increased alanine aminotransferase and high HBV-DNA levels. Three patients were in the immunotolerant phase, two were infected with HBV genotype A and one with genotype F. HBV subtyping showed subtypes adw2 and adw4. CONCLUSIONS:HBV genotype A adw2 and genotype F adw4 were the most prevalent isolates found. We could not find differences in genotype distribution according to HBV clinical phases and DNA levels. We did not detect HBV genotype D in contrast to a previous study in our center with acute hepatitis B. All inactive HBsAg carriers had low HBV-DNA levels.
Authors: Elisabeth Lampe; Francisco C A Mello; Marcia P do Espírito-Santo; Cintia M C Oliveira; Dennis A Bertolini; Neiva S L Gonçales; Regina C Moreira; Carlos A S Fernandes; Haydée C L Nascimento; Rejane M T Grotto; Maria Inês M C Pardini Journal: J Gen Virol Date: 2017-06-20 Impact factor: 3.891
Authors: Mónica V Alvarado-Mora; Livia Botelho; Michele S Gomes-Gouvêa; Vanda F de Souza; Maria C Nascimento; Claudio S Pannuti; Flair J Carrilho; João Rr Pinho Journal: Virol J Date: 2011-08-25 Impact factor: 4.099
Authors: Francisco C A Mello; Francisco J D Souto; Leticia C Nabuco; Cristiane A Villela-Nogueira; Henrique Sergio M Coelho; Helena Cristina F Franz; Joao Carlos P Saraiva; Helaine A Virgolino; Ana Rita C Motta-Castro; Mabel M M Melo; Regina M B Martins; Selma A Gomes Journal: BMC Microbiol Date: 2007-11-23 Impact factor: 3.605
Authors: Barbara V Lago; Marcia P do Espirito-Santo; Vanessa D Costa; Vanessa A Marques; Livia M Villar; Lia L Lewis-Ximenez; Elisabeth Lampe; Francisco C A Mello Journal: Viruses Date: 2019-09-15 Impact factor: 5.048
Authors: Alba Maria Xavier Eloy; Regina Célia Moreira; Marcílio Figueiredo Lemos; Jéfferson Luis de Almeida Silva; Maria Rosângela Cunha Duarte Coêlho Journal: Braz J Infect Dis Date: 2013-09-07 Impact factor: 3.257